Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling
The current patent application deals with the inhibition of signalling through the cytokines IL-4 and IL-13. Pathologically increased activation of this signaling cascade is associated with asthma, atopic dermatitis and related diseases.
Further Information: PDF
GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120
Contact
Beate-Victoria Ermisch
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
The future of digital agriculture
The Center for Digital Agriculture showcased the many advancements in digital agriculture during its annual conference. When the Center for Digital Agriculture (CDA) launched in 2018, they were looking forward…
Physicists arrange atoms in extremely close proximity
The technique opens possibilities for exploring exotic states of matter and building new quantum materials. Proximity is key for many quantum phenomena, as interactions between atoms are stronger when the…
